News

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...
AN Venture Partners has closed its first fund, a $200 million vault for biotechs worldwide, with particular emphasis on ...
A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...
Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of ...
An Expert View from Justin Kozak, life sciences industry lead, Founder Shield.
BIO, a key biotech lobby group, labels RFK Jr. a public health threat amid vaccine skepticism. Read more here.
Odisha aims to establish a Science City in Bhubaneswar with central support, enhancing scientific innovation under 'Viksit ...
BioDlink, a leading global CDMO, hosted its 2025 Peer Advisory Board on June 26, 2025, spotlighting China's dynamic clinical trial and CDMO landscape as a global springboard for biotech innovation.
The Boston biotech has secured $33 million in venture capital and $5 million in NIH funding to advance its once-daily obesity pill.
The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and ...